Second phase of a major upgrade project to build a world-class particleboard, TFL facility.
Enhances manufacturing capabilities and export capacity.
Expanded strategic deal includes equipment and co-commercialization.
R&D project will expand Shenzhen Hepalink’s product line and diversification efforts.
30 employees affected, production moving to NY and Laval.
Shift your gaze a little to the left at its protectionist leanings.
NantPro will manufacture plasma-derived product for US market.